UNCLAIMED
Medpace
Overview
Medpace is a United States-based company operating within the Business Services sector, specifically focusing on research and development in the biotech and pharmaceutical industries. Founded in 1992, Medpace employs between 5,001 and 10,000 individuals and has reported significant revenue, indicating a robust operational scale. The company specializes in clinical laboratory services, with a documented emphasis on advancing clinical trials and research methodologies. Its published works include a whitepaper that discusses the direct measurement of Lp(a) cholesterol and its impact on the accuracy of LDL-C assessments in patients with elevated Lp(a), highlighting Medpace's commitment to improving clinical outcomes through innovative research. Additionally, the company has produced an article on innovations in ophthalmology clinical trials, further showcasing its involvement in cutting-edge research within the healthcare sector. Medpace's focus on clinical research and laboratory services positions it as a significant player in the ongoing development of medical and pharmaceutical advancements.